Avalon Globocare Corp
ALBT1.260USD
-0.020-1.56%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
5.16MMarket Cap
LossP/E TTM
More Details of Avalon Globocare Corp Company
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Avalon Globocare Corp Info
Ticker SymbolALBT
Company nameAvalon Globocare Corp
IPO dateFeb 22, 2016
CEOJin (David)
Number of employees5
Security typeOrdinary Share
Fiscal year-endFeb 22
Address4400 Route 9
CityFREEHOLD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07728
Phone17327804400
Websitehttps://www.avalon-globocare.com/
Ticker SymbolALBT
IPO dateFeb 22, 2016
CEOJin (David)
Company Executives of Avalon Globocare Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Nov 20
Updated: Thu, Nov 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
Geode Capital Management, L.L.C.
0.52%
Other
90.03%
Shareholders
Shareholders
Proportion
Lu (Wenzhao)
5.62%
Jin (David)
2.42%
Li (Meng)
0.81%
The Vanguard Group, Inc.
0.60%
Geode Capital Management, L.L.C.
0.52%
Other
90.03%
Shareholder Types
Shareholders
Proportion
Individual Investor
8.87%
Investment Advisor
0.60%
Investment Advisor/Hedge Fund
0.52%
Hedge Fund
0.01%
Other
90.00%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
29
48.23K
1.25%
--
2025Q3
31
48.23K
1.39%
+17.57K
2025Q2
33
19.75K
2.15%
+2.84K
2025Q1
33
16.91K
2.05%
-16.99K
2024Q4
35
16.66K
2.06%
-67.00
2024Q3
33
16.73K
1.75%
-236.00
2024Q2
33
16.96K
1.41%
+10.31K
2024Q1
31
6.65K
1.69%
-5.84K
2023Q4
32
10.45K
1.58%
+1.42K
2023Q3
39
9.06K
1.97%
+456.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Lu (Wenzhao)
238.93K
6.23%
+9.00
+0.00%
Mar 31, 2025
Jin (David)
103.00K
2.69%
--
--
Mar 31, 2025
Li (Meng)
34.33K
0.9%
+1.00
+0.00%
Mar 31, 2025
The Vanguard Group, Inc.
1.58K
0.04%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
9.34K
0.24%
--
--
Aug 31, 2025
Tauzin (Wilbert J II)
1.04K
0.03%
+1.04K
--
Mar 31, 2025
Tower Research Capital LLC
241.00
0.01%
+241.00
--
Jun 30, 2025
Citi Investment Research (US)
951.00
0.02%
+951.00
--
Jun 30, 2025
BofA Global Research (US)
113.00
0%
+7.00
+6.60%
Jun 30, 2025
UBS Financial Services, Inc.
4.20K
0.11%
+1.64K
+64.05%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Date
Type
Ratio
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
FAQs
Who are the top five shareholders of Avalon Globocare Corp?
The top five shareholders of Avalon Globocare Corp are:
Lu (Wenzhao) holds 238.93K shares, accounting for 6.23% of the total shares.
Jin (David) holds 103.00K shares, accounting for 2.69% of the total shares.
Li (Meng) holds 34.33K shares, accounting for 0.90% of the total shares.
The Vanguard Group, Inc. holds 1.58K shares, accounting for 0.04% of the total shares.
Geode Capital Management, L.L.C. holds 9.34K shares, accounting for 0.24% of the total shares.
Lu (Wenzhao) holds 238.93K shares, accounting for 6.23% of the total shares.
Jin (David) holds 103.00K shares, accounting for 2.69% of the total shares.
Li (Meng) holds 34.33K shares, accounting for 0.90% of the total shares.
The Vanguard Group, Inc. holds 1.58K shares, accounting for 0.04% of the total shares.
Geode Capital Management, L.L.C. holds 9.34K shares, accounting for 0.24% of the total shares.
What are the top three shareholder types of Avalon Globocare Corp?
The top three shareholder types of Avalon Globocare Corp are:
Lu (Wenzhao)
Jin (David)
Li (Meng)
Lu (Wenzhao)
Jin (David)
Li (Meng)
How many institutions hold shares of Avalon Globocare Corp (ALBT)?
As of 2025Q4, 29 institutions hold shares of Avalon Globocare Corp, with a combined market value of approximately 48.23K, accounting for 1.25% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.14%.
What is the biggest source of revenue for Avalon Globocare Corp?
In --, the -- business generated the highest revenue for Avalon Globocare Corp, amounting to -- and accounting for --% of total revenue.
